AstraZeneca's COVID-19 vaccine, Vaxzevria, has been approved for use in the EU as a third dose for adult revaccination. The vaccine can now be used as a booster after two doses of the company's vaccine or by those who were previously vaccinated with mRNA vaccine made by Pfizer and BioNTech or Moderna.
AstraZeneca's COVID-19 vaccine, Vaxzevria, has been approved for use in the EU as a third dose for adult revaccination. The vaccine can now be used as a booster after two doses of the company's vaccine or by those who were previously vaccinated with mRNA vaccine made by Pfizer and BioNTech or Moderna. 
reuters.com
English (US) 